west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "曲霉菌" 15 results
  • The Interpretation of Diagnosis and Treatment Guidelines of Aspergillosis from Infectious Diseases Society of America in 2008

    Release date: Export PDF Favorites Scan
  • Detection of Invasive Aspergillosis by Serum Galactomannan Test: A Systematic Review

    Objective To assess the quality of current domestic literature about enzyme-linked immunosorbent assay (ELISA) for invasive aspergillosis diagnosis by detecting Aspergillus galactomannan (GM) antigen, and to analyze the sources of bias and variability, as well as the diagnostic ability of different thresholds. Methods Both computer-based online search and manual retrieval were employed to identify relevant articles. The statistical information and quality of science were assessed and classified. The data were analyzed using Meta Disc 1.4 software. The best cutoff value for defining a positive test result was selected by summarizing the following statistical indicators as sensitivity, specificity, likelihood ratio (LR) and summary receiver operating characteristic curve (SROC curve), and by calculating the area under the curve (AUC) as well. Results A total of 20 studies among 2658 literatures were included in accordance with the inclusion criteria, and were divided into different groups based on different cutoff values. Though heterogeneity tests showed no threshold effect, and there were other reasons of heterogeneity. So the data were analyzed by random effects model. The results showed that, compared with other groups, the one with cutoff value set at 0.7 (AUC=0.9456, Q= 0.884 6) showed the best accuracy in diagnosing. Conclusion ELISA detection of Aspergillus GM antigen with cutoff value set at 0.7 has important significance in the early diagnosis of invasive aspergillosis, and it can be conducive to reduce mortality in patients at high risk for Aspergillus infection.

    Release date:2016-09-07 11:07 Export PDF Favorites Scan
  • 侵袭性肺曲霉菌感染诊治进展

    随着社会老龄化, 抗肿瘤药物、免疫抑制剂和器官移植等治疗的广泛开展, 在危重患者中广谱抗生素药物的长期应用, 与之伴随的是真菌感染发生的逐年增多, 其中侵袭性曲霉菌感染因其感染隐匿, 难以诊治和高死亡率等特点被临床医生所重视。按我国医院感染监控网分析, 医院真菌感染率从1993 ~1996 年的13. 9% 上升至1998 ~1999 年的17. 1% 、1999 ~2000 年的24. 4% 。侵袭曲霉菌病特别是肺部曲霉菌感染多发生在有严重基础疾病的患者,预后差, 病死率达50% ~100% [ 1 ] 。本文回顾相关研究文献中关于侵袭性肺曲霉菌诊治进展, 高危人群, 目前诊断检测技术的临床价值, 抗曲霉菌药物特点和治疗现状。

    Release date:2016-08-30 11:56 Export PDF Favorites Scan
  • 无哮喘的变应性支气管肺曲霉病一例

    目的 报道并分析1例变应性支气管肺曲霉病(allergic bronchopulmonary aspergillosis,ABPA)的临床特点、诊断及治疗方法。方法 结合文献资料分析我科2019年诊治的1例ABPA的病例。结果 该患者诊断明确,治疗稍有曲折。ABPA常发生于肺部有基础疾病者,尤其是支气管哮喘或囊性纤维化者。临床表现主要是咳嗽、咳痰、喘息、胸闷;实验室检查血清总IgE水平和曲霉特异性IgE水平上升,以及嗜酸性粒细胞数增加;胸部影像学表现为反复的肺部游走性浸润影和中心性支气管扩张等。治疗包括糖皮质激素和抗真菌治疗,对于不能耐受糖皮质激素的患者,抗IgE抗体治疗有益。结论 临床上ABPA容易误诊、误治,特别是无哮喘病史时,其诊断更加困难。因此早期诊断和正确治疗可以减少ABPA造成的肺损伤,改善患者的预后。

    Release date:2023-11-13 05:45 Export PDF Favorites Scan
  • Role of aspergillus infection in bronchiectasis and its diagnosis and treatment

    Bronchiectasis is a heterogeneous disease characterized by abnormal expansion of the bronchi, manifested by cough, sputum, and recurring lung infections. As one of the common fungi of lung infection, aspergillus can not only appear as the outcome of the disease in bronchiectasis, but also as an inducement to participate in the disease progression, and ultimately complicate the course of bronchiectasis. This article describes the susceptibility factors and pathogenic mechanisms of aspergillus in bronchiectasis, and further introduces the diagnosis and treatment status of bronchiectasis combined with aspergillus infection, aiming to clarify the effect of aspergillus infection on bronchiectasis and provide new thinking directions for its clinical diagnosis and treatment.

    Release date:2022-02-24 02:27 Export PDF Favorites Scan
  • Completely Video-assisted Thoracopic Surgery for Pulmonary Aspergilloma: A Case Control Study

    ObjectiveTo discuss the possibility and safety of video-assisted thoracoscope surgery for pulmonary aspergilloma. MethodsWe retrospectively analyzed the clinical data of 39 patients with pulmonary aspergilloma in Beijing Chaoyang Hospital between June 2009 and May 2014. The patients were divided into two groups according to their operation method including a conventional thoracotomy surgery group (open group, n=11) and a video-assisted thoracoscope pneumonectomy group (VATS group, n=28). There were 8 male patients and 3 female patients with age of 29-64 (50.7±9.7) years in the open group. There were 13 male patients and 15 female patients with age of 20-75 (55.4±15.3) years in the VATS group. We compared clinical effectiveness between the two groups. ResultsThe operations of all patients were performed successfully. There were statistical differences between the two groups in the average length of operative time (P=0.001), the loss of intraoperative blood (P=0.005), and the score of pain (P=0.001). There was no statistical difference in lead flow of postoperative chest (P>0.05) and the time of hospitalization (P>0.05). ConclusionVideo-assisted thoracoscope surgery in the treatment of pulmonary aspergilloma could be feasible, safe, and effective based on our study. It is worth of clinical application and popularization.

    Release date: Export PDF Favorites Scan
  • Effects of Aspergillus fumigatus spores on airway inflammation and airway responsiveness on asthmatic rat model

    Objective To explore the effects of Aspergillus fumigatus(A. fumigatus) spores on airway inflammation and responsiveness in asthmatic rats.Methods Seventy male Wistar rats were randomly divided into Ⅰ and Ⅱ groups(n=35 in each group),then Group Ⅰ and Group Ⅱ were subdivided into a normal control group(n=5),an asthma group(n=10),a spores-treated control group(n=10),and a spores-treated asthma group(n=10).The rats were sensitized to ovalbumin(OVA) and challenged with aerosol OVA to establish the asthma model.The effects of A. fumigatus spores on asthmatic rats before and after OVA aerosol challenging were investigated in Group Ⅰ and Group Ⅱ,respectively.The parameters associated with bronchial epithelial damage were observed by total protein concentration in BALF measured by BCA method.Total and differential cell counts in BALF were also counted.The airway resistance and airway responsiveness were calculated by transpulmonary pressure and gas flow rate.Results In Group Ⅰ,the total protein in BALF in the asthma group treated with A. fumigatus spores before OVA challenging(Group CA) was increased remarkably compared to the asthma group(Group A1)[(1.125±0.254)μg/mL vs(0.825±0.173)μg/mL,Plt;0.01].The nonspecific airway resistances induced by different concentration of acetylcholine in Group CA [(0.997±0.196)cm H2O•mL-1•s-1,(1.123±0.142)cm H2O•mL-1•s-1,(1.130±0.197)cm H2O•mL-1•s-1]were increased significantly compared to Group A1 [(0.655±0.089)cm H2O•mL-1•s-1,(0.687±0.048)cm H2O•mL-1•s-1,(0.821±0.043)cm H2O•mL-1•s-1](all Plt;0.05).In Group Ⅱ,however,the above parameters in the asthma group treated with A. fumigatus spores after OVA challenging(Group AC) were not dramatically increased compared with the asthma group(Group A2)(all Pgt;0.05).The differences in the total and differential cell counts in BALF in Group CA were not remarkable compared to other subgroups in Group Ⅰ(all Pgt;0.05).But the BALF neutrophil count in Group AC was increased obviously compared to Group A2 [(2.488±0.420)×106 vs (0.936±0.459)×106,Plt;0.05].Conclusion These data indicate that exposure to A. fumigatus spores before challenging causes aggravated epithelial damage and increased airway resistance in an asthma rat model.

    Release date:2016-08-30 11:35 Export PDF Favorites Scan
  • Diagnosis and Surgical Treatment of Pulmonary Tuberculosis Complicated by Aspergillus Infection

    Objective To investigate diagnosis and treatment strategies of patients with pulmonary tuberculosis (TB) complicated by Aspergillus infection. Methods Clinical data of 38 patients with pulmonary TB complicated by Aspergillus infection who underwent surgical treatment from January 2008 to December 2010 in Chengdu Infectious Disease Hospital were retrospectively analyzed. There were 23 male patients and 15 female patients with their average age of 37.8 (23-59) years. Preoperatively,all the patients received regular anti-TB treatment for more than 2 weeks,and patients with definite Aspergillus infection received anti-Aspergillus therapy for more than 3 days with consultation of infectious disease physicians. After above treatment,26 patients underwent lobectomy,1 patient underwent right pneumonectomy,and 11 patients underwent left pneumonectomy. All the patients were followed up at the outpatient department after discharge. They were evaluated every 2 weeks in the first 3 months,every 1 month after 3 months,and every 6 months after 1 year. During follow-up,they received acid-fast bacillus smear and sputum culture to check Aspergillus,as well as CT chest scan. Results All the patients successfully received surgical resection of the pulmonary lesion without perioperative death or severe complication. Postoperative pathology examination confirmed pulmonary TB with Aspergillosis infection in all the 38 patients,whose basic diseases included TB cavity in 17 patients,TB-destroyed lung in 12 patients,and post-TB bronchiectasis in 9 patients. All the patients were followed up after discharge for 1.5-4.5 years. During follow-up,they received regular anti-TB therapy for adequate duration in addition to antifungal medications such as voriconazole. None of the 38 patients had recurrence of Aspergillus infection or pulmonary TB. One patient had hemoptysis which was controlled after proper treatment during follow-up. Conclusion Missed diagnosis rate of pulmonary TB complicated by Aspergillus infection is high. Surgical resection of the pulmonary lesion and postoperative medication treatment are the most effective treatment strategies for patients with pulmonary TB complicated by Aspergillus infection.

    Release date:2016-08-30 05:46 Export PDF Favorites Scan
  • 长期服用糖皮质激素及免疫抑制剂致肺曲霉菌感染一例

    Release date:2016-09-07 02:34 Export PDF Favorites Scan
  • 侵袭性肺迟缓曲霉病一例报道

    目的 通过本病例及综述以提升对侵袭性肺迟缓曲霉病早期病原学诊断的重视,并为治疗方案提供参考依据。方法 回顾我科诊治的1例COVID-19感染后继发的侵袭性肺迟缓曲霉病患者的临床资料,复习既往文献总结分析肺迟缓曲霉病的临床表现、诊断及治疗用药方案。结果 患者79岁,老年男性,咳嗽、咳痰伴呼吸困难4月余。胸部CT提示:双肺数个结节灶,部分结节内空洞形成;散在实变影。G实验、GM结果阴性。气管镜肺泡灌洗液送检mNGS查见迟缓曲霉菌。给予伏立康唑治疗后效不佳,且继发肝功能异常,调整为艾沙康唑治疗后临床症状及肺部影像学征象好转。复习文献,共有12例个案报道,其中8例存在免疫抑制状态,4例合并慢性阻塞性肺病,6例为器官移植术后。临床选药以伏立康唑和两性霉素B居多,虽经治疗仍有66.7%(8例)患者在确诊后7周内死亡。结论 本例为国内外首次使用艾沙康唑成功治疗侵袭性肺迟缓曲霉病的报告。侵袭性肺迟缓曲霉病属于罕见病,免疫抑制状态是其高危因素。该病进展迅速,具有高度耐药性,预后差,病死率高,早期病原学诊断尤为关键。

    Release date: Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content